LUNG

Pulmonx Corp. is a commercial-stage medical technology company focused on minimally invasive treatments for chronic obstructive pulmonary disease (COPD) and emphysema. The company developed the Zephyr Endobronchial Valve, a small one-way valve implanted in the airways to help severe emphysema patients breathe more easily. Their products are designed to reduce lung hyperinflation without surgery.